Business Wire

Reply: Automation and Artificial Intelligence Are the Strategic Keys for an Effective Defense Against Growing Threats in the Digital World

30.5.2022 12:35:00 EEST | Business Wire | Press release

Share

Today, cybersecurity represents an essential priority in the implementation of new technologies, especially given the crucial role that they have come to play in our private and professional lives. Smart Homes, Connected Cars, Delivery Robots: this evolution will not stop and so, in tandem, it will be necessary to develop automated and AI-based solutions to combat the growing number of security threats. The risks from these attacks are attributable to several factors, such as increasingly complex and widespread digital networks and a growing sensitivity to data privacy issues. These are the themes that emerge from the new “ Cybersecurity Automation ” research conducted by Reply, thanks to the proprietary SONAR platform and the support of PAC (Teknowlogy Group) in measuring the markets and projecting their growth.

In particular, the research estimates the principal market trends in security system automation, based on analysis of studies of the sector combined with evidence from Reply’s own customers. The data compares two different clusters of countries: the “Europe-5” (Italy, Germany, France, the Netherlands, Belgium) and the “Big-5” (USA, UK, Brazil, China, India) in order to understand how new AI solutions are implemented in the constantly evolving landscape of cybersecurity.

As cyberattacks like hacking, phishing, ransomware and malware have become more frequent and sophisticated, resulting in trillions of euros in damages for businesses both in terms of profit and brand reputation, the adoption of hyperautomation techniques has demonstrated how artificial intelligence and machine learning represent possible solutions. Furthermore, these technologies will need to be applied at every stage of protection, from software to infrastructure, and from devices to cloud computing.

Of the 300 billion in investments that the global cybersecurity market will make in the next five years, a large part will be directed toward automating security measures in order to improve detection and response times to threats in four different segments: Application security, Endpoint security, Data security and protection, Internet of Things security.

Application Security. Developers who first introduced the concept of “security by design,” an adaptive approach to technology design security, are now focusing on an even closer collaboration with the operations and security teams, termed DevSecOps. This newer model emphasizes the integration of security measures throughout the entire application development lifecycle. Automating testing at every step is crucial for decreasing the number of vulnerabilities in an application, and many testing and analysis tools are further integrating AI to increase their accuracy or capabilities. Investments in application security automation in the Europe-5 market are expected to see enormous growth, around seven times the current value, reaching 669 million euros by 2026. A similar growth is forecast in the Big-5 market, with investments rising to 3.5 billion euros.

Endpoint security. Endpoints, such as desktops, laptops, smartphones and servers, are sensitive elements and therefore possible sources of entry for cyberattacks if not adequately protected. In recent years, the average number of endpoints within a company has significantly increased, so identifying and adopting efficient and comprehensive protection tools is essential for survival. Endpoint detection and response (EDR) and Extended detection and response (XDR) are both tools created to accelerate the response time to emerging security threats, delegating repetitive and monotonous tasks to software that can manage them more efficiently. Investments in these tools are expected to increase in both the Europe-5 and Big-5 markets over the next few years, reaching 757 million euros and 3.65 billion euros respectively. There are also a multitude of other tools and systems dedicated to incident management that can be integrated at the enterprise level. For example, in Security Orchestration Automation and Response (SOAR) solutions, AI can be introduced in key areas such as threat management or incident response.

Data security and protection. Data security threats, also called data breaches, can cause significant damage to a business, resulting in risky legal complications or devaluating brand reputation. Ensuring that data is well-preserved and well-stored is an increasingly important challenge. It is easy to imagine how many different security threats can come from poor data manipulation, cyberattacks, untrustworthy employees, or even just from inexperienced technology users. Artificial intelligence is a tool for simplifying these data security procedures, from discovery to classification to remediation. Security automation is expected to reduce the cost of a data breach by playing an important role in various phases of a cyberattack, such as in data loss prevention tools (DLP), encryption, and tokenization. In an effort to better protect system security and data privacy, companies in the Europe-5 cluster are expected to invest 915 million euros in data security automation by 2026. The Big-5 market will quadruple its value, reaching 4.4 billion euros in the same timeframe.

Internet of Things security. The interconnected nature of IoT allows for every device in a network to be a potential weak point, meaning even a single vulnerability could be enough to shut down an entire infrastructure. By 2026, it is estimated that there will be 80 billion IoT devices on earth. The impressive range of abilities offered by IoT devices for different industries, though enabling smart factories, smart logistics, or smart speakers, prevents the creation of a standardized solution for IoT cybersecurity. As IoT networks reach fields ranging from healthcare to automotive, the risks only multiply. Therefore, IoT security is one of the most difficult challenges: the boundary between IT and OT (Operational Technology) must be overcome in order for IoT to unleash its full business value. As such, it is estimated that the IoT security automation market will exceed the 1-billion-euro mark in the Europe-5 cluster by 2026. In the Big-5 market, investments will reach a whopping 4.6 billion euros.

Filippo Rizzante, Reply’s CTO, has stated: “The significant growth that we are witnessing in the cybersecurity sector is not driven by trend, but by necessity. Every day, cyberattacks hit public and private services, government and healthcare systems, causing enormous damage and costs; therefore, it is more urgent than ever to reconsider security strategies and reach new levels of maturity through automation, remembering that though artificial intelligence has increased the threat of the hacker, it is through taking advantage of AI’s opportunities that cyberattacks can be prevented and countered.”

The complete research is downloadable here. This new research is part of the Reply Market Research series, which includes the reports “From Cloud to Edge”, “Industrial IoT: a reality check” and “Hybrid Work.”

Reply
Reply [EXM, STAR: REY, ISIN: IT0005282865] is specialized in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly focused companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of AI, cloud computing, digital media and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contacts
Reply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594

Aaron Miani
a.miani@reply.com
Tel. +44 (0)20 7730 6000

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye